Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
used Paxlovid in the past. were positive/ 3 years ago...2021, that they took it; used Paxlovid in the past. were positive/ 3 years ago...2021, that they took it; This is a spontaneous report received from a Physician. A 72-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "used Paxlovid in the past. were positive/ 3 years ago...2021, that they took it". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2021) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for [BNT162B2] will be requested and submitted if and when received.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162b2 in this patient cannot be completely excluded. The patient's predispositions such as old age associated immunosenescence may contribute to suboptimal response after vaccination.,Linked Report(s) : US-PFIZER INC-202500076435 Same reporter/ drug/ event for different patients.;
Test Date: 2021; Test Name: Covid-19; Test Result: Positive